New drug KHN707 enters first human safety trial in china
NCT ID NCT07557537
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tests whether KHN707 tablets are safe and how the body processes them. About 38 healthy Chinese adults aged 18-45 will receive either the drug or a placebo. The goal is to check for side effects and measure drug levels in the blood, not to treat any disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT PARTICIPANTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new pill ACC017 be safely dosed? a trial seeks answers
- Can a fingerprint scan replace traditional drug tests?
- Gut feeling: could probiotics soothe the mind?
- A window to the brain? eye signals may track dopamine
- Can a common heartburn pill change how a cancer drug works?
- Breathing exercises may rewire tongue control — a pilot study puts the idea to the test